Perspective of patients with autoimmune diseases on COVID-19 vaccination
L Boekel, F Hooijberg, ZLE van Kempen… - The Lancet …, 2021 - thelancet.com
L Boekel, F Hooijberg, ZLE van Kempen, EH Vogelzang, SW Tas, J Killestein…
The Lancet Rheumatology, 2021•thelancet.comThe socioeconomic burden of COVID-19 and pressure on health-care systems can only be
reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be
achieved, it has been estimated that, depending on the efficacy of the vaccines employed,
approximately 60–100% of the global population needs to be vaccinated.
reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be
achieved, it has been estimated that, depending on the efficacy of the vaccines employed,
approximately 60–100% of the global population needs to be vaccinated.
The socioeconomic burden of COVID-19 and pressure on health-care systems can only be reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be achieved, it has been estimated that, depending on the efficacy of the vaccines employed, approximately 60–100% of the global population needs to be vaccinated.
thelancet.com
